Skip to content

the Effect of Transcutaneous Electrical Acupoint Stimulation on the Quality of Oocyte on Poor Ovarian Response(POR)

The Clinical Trial of the Effect of Transcutaneous Electrical Acupoint Stimulation on the Quality of the Oocyte on Poor Ovarian Response

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03994614
Acronym
POR
Enrollment
92
Registered
2019-06-21
Start date
2020-01-01
Completion date
2021-05-01
Last updated
2022-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Poor Ovarian Response

Keywords

transcutaneous electrical acupoint stimulation, quality of oocyte, ovarian reserve, poor ovarian response, in vitro fertilization-embryo transfer

Brief summary

Patients in experimental group will be given transcutaneous electrical acupoint stimulation (TEAS) treatment for 12 weeks prior to controlled ovarian stimulation (COS).The patients will be given three times acupuncture every week except menstruation.Patients in no intervention group will not be given any interventions for 12 weeks prior to COS. The primary outcome measure is the number of MII eggs obtained in the COS cycle. The secondary outcome measures are the lab and clinical reproductive outcomes.

Detailed description

The patients will be randomly recruited into two groups. Patients in experimental group will be given TEAS treatment for 12 weeks prior to COS.The patients will be given three times acupuncture every week except menstruation. One treatment lasts for 30 minutes. The acupoints used for the TEAS treatment included head acupoint Baihui(DU20), abdominal acupoint Zhongji (RN3), Guanyuan (RN4), Zigong(EX-CA1), leg acupoint Sanyinjiao(SP6), waist acupoint Shenyu (BL23) and Guanyuanyu(BL26). Patients in no intervention group will not be given any intervention for 12 weeks prior to COS. When at least one dominant follicle is greater than 18 mm then injection a GnRH agonist (Triptorelin, Ferring, Switzerland) 0.2mg. 36 hours later transvaginal oocyte retrieval will be taken. After 3 hours of incubation, each egg will be transferred with a density of about 100,000/mllive sperm. The fresh embryo transfer is performed 72 hours after embryo culture in vitro. The whole embryos will be frozen. The primary outcome measure is the number of MII eggs obtained in the COS cycle. The secondary outcome measures are the lab and clinical reproductive outcomes,including basic endocrine, serum Anti-Mullerian Hormone (AMH), antral follicle counts, fertilization rate, cleavage rate, number of D3 embryos, the clinical pregnancy rate and early abortion rate.

Interventions

OTHERTEAS

Patients in the experimental group will be given TEAS treatment for 12 weeks prior to COS. The patients will be given three times acupuncture every week except menstruation. The acupuncture acupoint locations are as follows: head acupoint Baihui(DU20), abdominal acupoint Zhongji (RN3), Guanyuan (RN4), Zigong(EX-CA1), leg acupoint Sanyinjiao(SP6), waist acupoint Shenyu (BL23) and Guanyuanyu(BL26).

Sponsors

ShangHai Ji Ai Genetics & IVF Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

1. The poor ovarian response patients compliance with Bologna consensus 2. Age:20-45 year 3. Women undergoing IVF-ET because of infertility for more than one year.

Exclusion criteria

1. Patients with genital tract malformation. Uterine malformation (single uterus, double uterus, double uterus, untreated mediastinal uterus) and other effects affecting uterine cavity disease (adenomyosis, submucosal uterine fibroids, intrauterine adhesions and scar uterus) 2. Complicated with other medical diseases(Hypertension, diabetes, psychosis, hereditary diseases)

Design outcomes

Primary

MeasureTime frameDescription
The number of MII eggsone day after oocyte pickupThe number of MII eggs obtained in the COS cycle

Secondary

MeasureTime frameDescription
Basic Follicle stimulating hormone (FSH) valueOn Day two of menstruationBasic FSH value in mIU/ml
Basic Luteinizing hormone (LH) valueOn Day two of menstruationBasic LH in mIU/ml
Basic estrodiol valueOn Day two of menstruationBasic estrodiol in pg/ml
Serum AMH valueOn Day two of menstruationSerum AMH in ng/ml
antral follicle countantral follicle count On Day two of menstruationantral follicle count
fertilization ratefertilization rate calculated on 1 day after oocyte pickupfertilization rate
cleavage ratecleavage rate calculated on 2 days after oocyte pickupcleavage rate
the number of Day 3 embryosthe number of Day 3 embryos calculated on 3 days after oocyte pickupthe number of Day 3 embryos
clinical pregnancy rateclinical pregnancy rate calculated on the 6th gestational weekclinical pregnancy rate
early abortion rateearly abortion rate calculated on 12th week of pregnancyearly abortion rate

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026